<DOC>
	<DOCNO>NCT03090542</DOCNO>
	<brief_summary>In healthy subject receive require lipid lower therapy diabetes , use clinoptilolite ( GPUR ) result reduction absorb dietary cholesterol observe 6 day therapy .</brief_summary>
	<brief_title>GPur- Luminating Oral Cholesterol Kinetics Pilot Study</brief_title>
	<detailed_description />
	<criteria>Adults 18 year age Not receive require lipid lower therapy Willingness give inform consent Able keep dietary log Willing maintain consistent day day routine study ( major change lifestyle , exercise , food pattern , smoke habit , etc ) Current use oral lipid binding agent ( colesevelam , cholestyramine , ezetimibe ) fibrates , niacin statin Current use dietary supplement enrich fat soluble vitamin , mono/polyunsaturated fat ( fishoil etc . ) probiotic Any oral antibiotic use , currently within past 14 day Diabetes , Type I Type II Currently follow restrictive diet GI motility disorder ( irritable bowel syndrome , diabetic gastroparesis , etc ) Prior gastric bowel resection Inflammatory bowel disease ( Crohns , ulcerative colitis , diverticulitis , celiac sprue , etc ) Comorbidities anticipate life expectancy &lt; 12 month ESRD dialysis Known intolerance silicium aluminum compound Excess alcohol consumption ( &gt; 1 drink per day ) Pregnancy , nurse taking/using contraception Hepatobiliary disorder renal disease Plasma total cholesterol &gt; 240mg/dl Triglycerides &gt; 265.5 mg/dl No plantsterol enrich food product allow diet &amp; supplement BMI &gt; 35</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>